000 | 01187 a2200337 4500 | ||
---|---|---|---|
005 | 20250510210839.0 | ||
264 | 0 | _c19771229 | |
008 | 197712s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/s0140-6736(77)90905-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGalton, D A | |
245 | 0 | 0 |
_aInfection and second-remission rates in patients having immunotherapy for acute myeloid keukemia. _h[electronic resource] |
260 |
_bLancet (London, England) _cNov 1977 |
||
300 |
_a973 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Letter | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
650 | 0 | 4 | _aEvaluation Studies as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfections _xepidemiology |
650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _ximmunology |
650 | 0 | 4 | _aRemission, Spontaneous |
700 | 1 | _aKay, H E | |
700 | 1 | _aReizenstein, P | |
700 | 1 | _aPenchansky, M | |
700 | 1 | _aVogler, W R | |
700 | 1 | _aWhittaker, J A | |
773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8045 _gp. 973 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(77)90905-9 _zAvailable from publisher's website |
999 |
_c70422 _d70422 |